24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
05/07/2018
Biogas injected into the natural gas grid
29/06/2018
SENER celebrates 25 years in Catalonia
21/06/2018
Barcelona Synchrotron Park’s Commitment to Natural Capital
12/06/2018
50th anniversary: congratulations UAB!
06/06/2018
Natura Bissé: the construction of the new world headquarters is well on its way
30/05/2018
Les Dames de Cerdanyola make sense